Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:3D Systems Corporation (DDD) provides 3D printing and digital manufacturing solutions. The Zacks Consensus Estimate for its current year earnings has been revised 225% downward over the last 60 days.Eagle Bancorp, Inc. (EGBN) is the bank holding company for EagleBank. The Zacks Consensus Estimate for its current year earnings has been revised 8.7% downward over the last 60 days.FinWise Bancorp (FINW) is a bank holding company for FinW ...

3D Systems (DDD) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its innovative 3D-printed, patient-specific cranial implant solution, the VSP PEEK Cranial Implant.VSP PEEK Cranial Implant includes a complete FDA-cleared workflow comprising segmentation and 3D modeling software, the 3D Systems EXT 220 MED 3D printer, Evonik VESTAKEEP i4 3DF PEEK (polyetheretherketone), and a pre-defined production process.The VSP PEEK Cranial Implant integrates cutting-ed ...

FDA clearance enables wide-spread adoption of 3D Systems self-contained, cleanroom environment-based printing system, the EXT 220 MED, with medical-grade PEEK materials to deliver patient-specific cranial reconstruction solutions3D-printed PEEK implants using the EXT 220 MED successfully demonstrated in nearly 40 cranioplasties across Europe in recent monthsMarket for cranial reconstruction anticipated to exceed $2 billion by 2030FDA clearance establishes strong foundation for expanded application of these ...

3D Systems (DDD) recently announced that Wilting, an industrial machining and metal 3D printing service provider, has integrated two single laser DMP Flex 350 and one DMP Flex 350 Dual metal 3D printer into its manufacturing floor.The addition not only augments Wilting's production capacity but also enhances its materials portfolio, catering to the diverse needs of its client base.Wilting's journey into additive manufacturing has been significantly catalyzed by its collaboration with 3D Systems' Application ...

Addition of single and dual laser printers enables use of broader materials portfolio to address new applications with Titanium, Stainless SteelDMP Flex 350's best-in-class oxygen level (<25 ppm), inert atmosphere ensures exceptionally strong, accurate parts for precision applications ROCK HILL, S.C., March 12, 2024 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced that Wilting, an industrial machining and metal 3D printing service provider, has added two single laser DMP Flex 350 and one DMP Flex ...

Repurchasing approximately $110 million of 0% coupon, convertible senior notes at approximately 22% discount to par value Reduces remaining balance of outstanding notes to approximately $214 million, over 50% reduction from initial issued principal balance of $460 million, due 2026Reinforces balance sheet strength and maintains strong cash position to support operational needs ROCK HILL, S.C., March 05, 2024 (GLOBE NEWSWIRE) --  3D Systems (NYSE:DDD) ("the Company") today announced that it has entered into ...

After sliding by 11% last week, shares of 3D Systems (DDD 5.07%) have extended their decline this week after the company reported disappointing fourth-quarter results on Tuesday.According to data provided by S&P Global Market Intelligence, as of the market's close on Thursday, 3D Systems was down by 16.5% from the end of trading last week."Significant headwinds" plagued the company last quarter3D Systems reported fourth-quarter revenue of $114.8 million, well shy of analysts' expectations for $126.6 million ...

3d Systems (DDD -23.14%) stock sank in Wednesday's trading. The company's share price closed out the daily session down 23.1%, according to data from S&P Global Market Intelligence.3d Systems published its fourth-quarter results after the market closed yesterday, and the company posted sales and earnings results for the period that fell short of the market's expectations. In addition to underwhelming Q4 performance, the 3D printing specialist also issued forward guidance that fell short of Wall Street's exp ...

Financial Data and Key Metrics Changes - For the full year 2023, consolidated revenues were reported at $488 million, a decline of 9% from the prior year, primarily impacted by the dental orthodontics business [24][12] - The gross profit margin for 2023 was 40.7%, with a non-GAAP gross margin of 41.1%, reflecting a 130 basis-point improvement over the prior year [26] - Adjusted EBITDA for 2023 was negative $24.5 million, a decline of $18.7 million from the previous year [27] Business Line Data and Key Metrics Changes - The dental orthodontics business saw a significant decline of 39% year-over-year, contributing heavily to the overall revenue drop [12][24] - Industrial solutions revenues were approximately $275 million, a decline of about 1%, with growth in transportation and aerospace offsetting declines in jewelry [24] - Healthcare solutions delivered full-year revenues of $213 million, down approximately 18%, with personalized healthcare growing by 12% [24] Market Data and Key Metrics Changes - The overall market for 3D printing is expected to grow at a compounded annual growth rate of over 20%, translating to an $80 billion market opportunity over the next five to seven years [10] - The dental market, particularly for dentures, is projected to exceed $2 billion by 2028, presenting a significant opportunity for new products [17] Company Strategy and Development Direction - The company is focusing on restructuring initiatives to reduce costs while maintaining critical R&D investments for future growth [14][15] - There is a strong emphasis on expanding into personalized healthcare and regenerative medicine, with expectations to triple revenue in this segment over the next five years [17][20] - The company aims to maintain a balance between cost reduction and investment in growth initiatives, particularly in high-potential areas like regenerative medicine [14][20] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that 2023 was a challenging year, primarily due to macroeconomic factors affecting capital spending [12][22] - For 2024, the company expects revenues to be relatively flat, with a focus on improving gross margins and operating expenses [30] - Management expressed optimism about the recovery in demand for dental products and the potential for growth in personalized healthcare [34][17] Other Important Information - The company is in the process of completing its quarterly and year-end close, with actual results subject to change [3] - The company has a strong balance sheet with $331.5 million in cash and cash equivalents, down from $568.7 million at the end of 2022 [29] Q&A Session Summary Question: Is the dental business expected to grow in 2024? - Management indicated that the dental business is in the process of bottoming out, with expectations for a lift in demand primarily in materials and services [34] Question: What is the expected timeline for FDA approval of the NextDent product? - Management confirmed that once they receive 510(k) approval, they will be ready to market the product, with printing capacity already being prepared [36] Question: What is the current quarterly spending on regenerative medicine? - Management stated that approximately $10 million was spent last year on regenerative medicine, with a focus on pharmaceutical applications [38] Question: Was the revenue shortfall in Q4 primarily due to CapEx-driven issues? - Management clarified that the revenue shortfall was due to slow rolling purchase orders rather than market share loss, reflecting customer caution regarding capital expenditures [45] Question: What were the non-GAAP operating expenses for the quarter? - Non-GAAP operating expenses for Q4 were reported at approximately $66 million, with some temporary spikes due to specific investments [46][48]

February 28, 2024 Fourth Quarter and Full Year Welcome and Participants Dr. Jeffrey Graves President& Chief Executive Officer Jeffrey Creech Executive Vice President & Chief Financial Officer Andrew Johnson Executive Vice President, Chief Corporate Development Officer & Chief Legal Officer Mick McCloskey Vice President, Treasury & Investor Relations ...